Literature DB >> 15175157

Pin1 links the activities of c-Abl and p300 in regulating p73 function.

Fiamma Mantovani1, Silvano Piazza, Monica Gostissa, Sabrina Strano, Paola Zacchi, Roberto Mantovani, Giovanni Blandino, Giannino Del Sal.   

Abstract

Activation of p73 upon genotoxic treatment triggers apoptosis of tumor cells lacking functional p53 and involves the activities of c-Abl and p300. Here, we demonstrate that conformational changes of p73 catalyzed by the prolyl isomerase Pin1 are crucial in this pathway. Lack of Pin1 reduces p73 stability, hampering its accumulation upon genotoxic stress. Indeed, we show that upon treatment with chemotherapeutic drugs c-Abl enhances the phosphorylation-dependent interaction between Pin1 and p73, and this in turn promotes p73 acetylation by p300. Consistently, the ability of c-Abl and p300 to increase p73 stability and transcriptional activity requires Pin1. As a consequence, Pin1 appears to be essential for activation of the apoptotic response by endogenous p73.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175157     DOI: 10.1016/j.molcel.2004.05.007

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  65 in total

1.  Peptidyl-prolyl isomerase Pin1 controls down-regulation of conventional protein kinase C isozymes.

Authors:  Hilde Abrahamsen; Audrey K O'Neill; Natarajan Kannan; Nicole Kruse; Susan S Taylor; Patricia A Jennings; Alexandra C Newton
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

Review 2.  The origins and evolution of the p53 family of genes.

Authors:  Vladimir A Belyi; Prashanth Ak; Elke Markert; Haijian Wang; Wenwei Hu; Anna Puzio-Kuter; Arnold J Levine
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-16       Impact factor: 10.005

3.  Phosphorylation stabilizes Nanog by promoting its interaction with Pin1.

Authors:  Matteo Moretto-Zita; Hua Jin; Zhouxin Shen; Tongbiao Zhao; Steven P Briggs; Yang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-09       Impact factor: 11.205

4.  Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes.

Authors:  Lara Manganaro; Marina Lusic; Maria Ines Gutierrez; Anna Cereseto; Giannino Del Sal; Mauro Giacca
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

5.  Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.

Authors:  Prashant Rajbhandari; Greg Finn; Natalia M Solodin; Kiran K Singarapu; Sarata C Sahu; John L Markley; Kelley J Kadunc; Stephanie J Ellison-Zelski; Anastasia Kariagina; Sandra Z Haslam; Kun Ping Lu; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

Review 6.  Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

7.  Protein kinase C-dependent phosphorylation regulates the cell cycle-inhibitory function of the p73 carboxy terminus transactivation domain.

Authors:  Ulrika Nyman; Pinelopi Vlachos; Anna Cascante; Ola Hermanson; Boris Zhivotovsky; Bertrand Joseph
Journal:  Mol Cell Biol       Date:  2009-01-21       Impact factor: 4.272

Review 8.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

Review 9.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

10.  Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death.

Authors:  Stefania Gonfloni; Lucia Di Tella; Sara Caldarola; Stefano M Cannata; Francesca G Klinger; Claudia Di Bartolomeo; Maurizio Mattei; Eleonora Candi; Massimo De Felici; Gerry Melino; Gianni Cesareni
Journal:  Nat Med       Date:  2009-09-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.